Skip to main content

Scienture Holdings, Inc.

SCNX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001382574

No open-market purchases or sales by Scienture Holdings, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $709.1K in total; no superinvestor holds it.

Q1 2023 vs. Q4 2022

How the institutions holding Scienture Holdings, Inc. changed between Q4 2022 and Q1 2023.

All holders in Q1 2023All holders in Q4 2022

13F holders of SCNX: Q4 2022 compared with Q1 2023
MeasureQ4 2022Q1 2023Change
Holders1512−3
Shares928.9K236.4K−692.5K (−74.5%)
Value$376.0K$69.2K−$306.8K (−81.6%)

New holders (3)

Institutions that held Scienture Holdings, Inc. at the end of Q1 2023 but not at the end of Q4 2022.

Institutions new to SCNX in Q1 2023
InstitutionSharesValue% of portfolio
Virtu Financial LLC25,111$7.00K0.00%
Susquehanna International Group, LLP19,580$5.78K0.00%
Citigroup Inc4,169$1.23K0.00%

Sold out (6)

Institutions that held Scienture Holdings, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.

Institutions that sold out of SCNX in Q1 2023
InstitutionShares, Q4 2022Value, Q4 2022
Armistice Capital, LLC514,998$207.3K
Ridgewood Investments LLC61,896$24.9K
UBS Group AG11,315$4.53K
HRT Financial LP11,491$4.00K
Advisor Group Holdings, Inc.4,395$2.00K
Morgan Stanley4$2